Parkinson's disease and dopaminergic therapy—differential effects on movement, reward and cognition

ISSN： 1460-2156

Source： Brain, Vol.131, Iss.8, 2008-08, pp. : 2094-2105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET

By Cools R.

Brain, Vol. 125, Iss. 3, 2002-03 ,pp. : 584-594

Oxford University Press

Access to resources Recommend Favorite

Agonizing over dopaminergic replacement therapy-lessons from animal models of parkinson's disease

By Stoessl A.J.

Experimental Neurology, Vol. 183, Iss. 1, 2003-09 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Selective IGT decision-making impairment in a patient with juvenile Parkinson's disease and pathological gambling: A role for dopaminergic therapy?

By Pignatti Riccardo

Neurocase, Vol. 18, Iss. 6, 2012-12 ,pp. : 503-513

Routledge Ltd

Access to resources Recommend Favorite

Movement disorders: Parkinson's disease dominates

By Pollak P.

Lancet Neurology, Vol. 3, Iss. 1, 2004-01 ,pp. : 15-15

Elsevier

Access to resources Recommend Favorite

Neuroprotective Therapy for Parkinson's Disease

By Koller W.C.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 24-28

Elsevier

Access to resources Recommend Favorite